Business · 1 sources covering this

AstraZeneca Pharma Q1 Results: Net Profit Falls 32% To Rs 38 Crore, Revenue Growth At 30% YoY

AstraZeneca Pharma India's revenue from operations in the quarter ended June 2026 grew 29.8% to Rs 682.8 crore from Rs 526.3 crore, year-on-year (YoY).

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·3h ago
AstraZeneca Pharma Q1 Results: Net Profit Falls 32% To Rs 38 Crore, Revenue Growth At 30% YoY
AstraZeneca Pharma India's revenue from operations in the quarter ended June 2026 grew 29.8% to Rs 682.8 crore from Rs 526.3 crore, year-on-year (YoY).
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/11eedf4781770bb18fa3148c0003704ab5c84ea4"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="AstraZeneca Pharma Q1 Results: Net Profit Falls 32% To Rs 38 Crore, Revenue Growth At 30% YoY"></iframe>

AstraZeneca Pharma Q1 Results: Net Profit Falls 32% To Rs 38 Crore, Revenue Growth At 30% YoY

How 1 sources are covering this

AstraZeneca Pharma Q1 Results: Net Profit Falls 32% To Rs 38 Crore, Revenue Growth At 30% YoY

More from Business

India’s QS-ranked institutions nearly 5X since 2015

Trai directs utilities, courier and logistics providers to use 1601 series

RPSG Group’s Purvah Green to acquire 1.4 GWp solar plants from ReNew Solar for ₹4,859 crore

Sold property at low price but seller wins tax case

Reader

Trust & legal

Across the network